Category: Pharmaceuticals
Australia Pharmaceuticals
-
2025 Australia Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
Cannabis in Australia
... pain, medical cannabis is becoming more widely known. Applications for special access have increased more than 100% in two years. As more competitors join the market and with imports representing 80% of the market, local ... Read More
-
Veterinary Pharmaceutical Manufacturing in Australia - Industry Market Research Report
... has been volatile thanks to seasonal weather patterns that battered farmers with either prolonged drought conditions or escalating flood waters. Livestock numbers fell in the face of these extreme conditions and with-it tumbled demand for ... Read More
-
2024-2029 Australia Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Barriers and Risks
... Pipeline, Emerging Opportunities for Suppliers, Market Barriers and Risks This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The ... Read More
-
Online Vitamin and Supplement Sales in Australia - Industry Market Research Report
... Australians adopt a holistic approach to their health and wellbeing, driving demand for vitamins and dietary supplements. Increased knowledge of the benefits associated with taking vitamins and dietary supplements and long-term population trends are also ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Australia Diabetes Market Forecast Report by Type (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare) and Company Analysis 2024-2032
... is expected to reach US$ 579.4 Million in 2023 to US$ 1,115.7 Million by 2032, with a CAGR of 7.55% from 2024 to 2032. The market is mainly driven by rising obesity rates, increased use ... Read More
-
Asia Pacific Corporate Wellness Market, By Service Type (Health Risk Assessment, Nutrition & Weight Management, Smoking Cessation, Fitness Services, Stress Management, Health Screening & Assessment, Employee Assistance Programs (EAPs)); By Delivery Model (On-site Programs, Off-site Programs); By Category (Fitness & Nutrition Consultants, Psychological Therapists, Organizations/Employers, Fitness & Medical Institutions); By End User (Small Scale Organizations, Medium Scale Organizations, Large Scale Organizations); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... of increasing prevalence of lifestyle-related diseases, a growing emphasis on employee productivity, and expanding wellness program offerings in workplaces. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Asia ... Read More
-
2024-2029 Australia Anemia Diagnostic Testing Market Assessment - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities for New Analyzers and Consumables ... Read More
-
Biotechnology in Australia - Industry Market Research Report
... part of product development in a variety of sectors, with businesses using biotech applications to address many social and economic issues, including human health, food security and alternative fuels. Several companies have reached commercial readiness, ... Read More
-
Vitamin and Supplement Manufacturing in Australia - Industry Market Research Report
... industry growth as demand for Australian 'clean and green' vitamins and supplements from Asian consumers surged. In 2018-19, exports to China increased three-fold as Chinese consumers favoured Australian vitamin brands because of their reputation for ... Read More
-
Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report
... disease. Increased local and global demand for consumer healthcare products has also benefited several participants. However, ongoing challenges including a changing regulatory and risk environment and reform-driven pricing pressures have constrained the industry's growth. Ongoing ... Read More
-
Australia and New Zealand Nutritional Supplements Market (Powder, Tablets, Capsules, Liquid, Soft Gels, Others); By Product Type (Sports Nutrition, Dietary Supplements, Fat Burner, Functional Food, Others); By Age Group (Kids, Adults, Geriatric); By Distribution Channel (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Australia & New Zealand Nutritional Supplements Market Booming to Surpass USD 9.7 Billion by 2030 Australia & New Zealand Nutritional Supplements Market ... Read More
-
Consumer Health in Australia
... suffering, as some consumers are also being forced to reduce spending on essentials such as groceries to keep up with bills and debts. In general, consumer health is a resilient industry. Categories such as analgesics ... Read More
-
Sleep Aids in Australia
... remains evident in Australia with many, particularly consumers aged 18-30 years, seeking help for anxiety, poor sleep quality and unhealthy sleep habits. In addition, the review period has seen surging inflation rates, higher interest rates, ... Read More
-
Dietary Supplements in Australia
... be attributable partly to price-driven growth, dietary supplements continues to grow in retail volume terms across much of the category. This highlights that spending on dietary supplements has been maintained amidst a difficult economic climate ... Read More
-
Analgesics in Australia
... 2023, the TGA has given manufacturers and retailers until February 2025 to adjust to the new measures, which have been driven by the need for a harm reduction approach to curb the high rates of ... Read More
-
Paediatric Consumer Health in Australia
... products, the move has impacted chewable tablet formats. Announced by the TGA in May 2023, the new restrictions on acetaminophen include: reducing the maximum size of packs available for general sale (such as through supermarkets ... Read More
-
Digestive Remedies in Australia
... impacted consumer spending – in conjunction with higher interest rates and the rapid rise in the cost of living. Consumer Price Index (CPI) indicators reveal that spending on health, including pharmaceuticals, rose by 5.3% year-on-year ... Read More
-
Dermatologicals in Australia
... February 2024), skin conditions (including skin rashes, eczema and psoriasis) had a moderate to severe impact on everyday life for 49% of respondents in Australia, the highest rate on record since tracking began in 2019 ... Read More
-
NRT Smoking Cessation Aids in Australia
... Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and ... Read More
-
Vitamins in Australia
... Australian consumers and those who are able to spend additional money on maintaining their general wellbeing through supplementation are willing to do so despite recent price increases. While single vitamins holds higher value share, multivitamins ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Australia
... September. While there was a concerning early start to the flu season in 2024, with unseasonably high rates of influenza and respiratory syncytial virus (RSV), as well as the nation’s first surge in whooping cough ... Read More
-
Dental Services in Australia - Industry Market Research Report
... industry is predominantly privately funded. While most individuals pay for dental check-ups and procedures with their own income, some use private health insurance extras cover to subsidise the cost. Patients with private health coverage tend ... Read More
-
Pharmaceuticals in Australia
... key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the ... Read More
Research Assistance
